Suchergebnisse - "Asai, Shiko"

PubPharm (25)

1

Subacute Thyroiditis Developing Within 2 Days of Vaccination Against COVID-19 with BNT162b2 mRNA

enthalten in: European journal of case reports in internal medicine | 2023

von Ie, K. | Ishizuka, K. | Sakai, T. | +3

2

IgG4-related hypophysitis diagnosed by retroperitoneal mass biopsy in a patient presenting with abducens nerve palsy : A case report (CARE-compliant article)

enthalten in: Medicine | 2020

von Imai, T. | Shibata, S. | Shinohara, K. | +5

3

In the overnight dexamethasone suppression test, 1.0 mg loading is superior to 0.5 mg loading for diagnosing subclinical adrenal Cushing's syndrome based on plasma dexamethasone levels determined using liquid chromatography-tandem mass spectrometry

enthalten in: Endocrine journal | 2017

von Sasaki, Y. | Katabami, T. | Asai, S. | +2

4

Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment Improves Survival in Patients with Metastatic and Unresectable Malignant Pheochromocytomas/Paragangliomas

enthalten in: Hormones & cancer | 2017

von Asai, S. | Katabami, T. | Tsuiki, M. | +2

5

Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment Improves Survival in Patients with Metastatic and Unresectable Malignant Pheochromocytomas/Paragangliomas

enthalten in: Hormones and cancer | 2017

von Asai, S. | Katabami, T. | Tsuiki, M. | +2

6

Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment Improves Survival in Patients with Metastatic and Unresectable Malignant Pheochromocytomas/Paragangliomas

enthalten in: Hormones and cancer | 2017

von Asai, S. | Katabami, T. | Tsuiki, M. | +2

7

Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment Improves Survival in Patients with Metastatic and Unresectable Malignant Pheochromocytomas/Paragangliomas

enthalten in: Hormones and cancer | 2017

von Asai, S. | Katabami, T. | Tsuiki, M. | +2

8

In the overnight dexamethasone suppression test, 1.0 mg loading is superior to 0.5 mg loading for diagnosing subclinical adrenal Cushing's syndrome based on plasma dexamethasone levels determined using liquid chromatography-tandem mass spectrometry

enthalten in: Endocrine journal | 2017

von Sasaki, Y. | Katabami, T. | Asai, S. | +2

9

Contralateral adrenal suppression on adrenocortical scintigraphy provides good evidence showing subclinical cortisol overproduction from unilateral adenomas

enthalten in: Endocrine journal | 2016

von Katabami, T. | Ishii, S. | Obi, R. | +2

10

Immunohistochemical analysis of insulin-like growth factor 1 and its receptor in sporadic schwannoma/peripheral nerve sheath tumour

enthalten in: The Journal of international medical research | 2016

von Matsubara, F. | Katabami, T. | Asai, S. | +9